Processa Pharmaceuticals
PCSA
PCSA
20 hedge funds and large institutions have $350K invested in Processa Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
49% less capital invested
Capital invested by funds: $691K → $350K (-$342K)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21.4K | |
| 2 | +$13.4K | |
| 3 | +$12K | |
| 4 |
HF
HRT Financial
New York
|
+$4K |
| 5 |
Renaissance Technologies
New York
|
+$2.05K |
Top Sellers
| 1 | -$29.7K | |
| 2 | -$14K | |
| 3 | -$9.96K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$5.32K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.32K |